Protein Purification and Isolation Global Market Report 2025

Protein purification and isolation involve the procedures used to separate a specific protein of interest from its surroundings, whether obtained from a cell culture in a laboratory or from the natural environment within a host organism. This process helps identify the existence of the protein from its source based on differences in their properties.

The main types of protein purification and isolation tools are instruments and consumables. Instruments are devices employed to carry out protein purification and isolation processes, which include extraction, precipitation, differential solubilization, ultracentrifugation, and various chromatographic methods. Technologies utilized in these processes encompass ultrafiltration, precipitation, preparative chromatography, electrophoresis, western blotting, dialysis and diafiltration, as well as centrifugation. The end-users of these technologies span academic medical institutes, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, and contract research organizations. Applications for protein purification and isolation include drug screening, protein-protein interaction studies, biomarker discovery, target identification, protein therapeutics, disease diagnostics, and monitoring.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The protein purification and isolation market research report is one of a series of new reports from The Business Research Company that provides protein purification and isolation market statistics, including protein purification and isolation industry global market size, regional shares, competitors with an protein purification and isolation market share, detailed protein purification and isolation market segments, market trends and opportunities, and any further data you may need to thrive in the protein purification and isolation industry. This protein purification and isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The protein purification and isolation market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.36 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased research and development in biopharmaceuticals, growth of The biotechnology industry, rising demand for high-quality proteins, expansion of academic and research institutes, advancements in chromatography techniques.

The protein purification and isolation market size is expected to see rapid growth in the next few years. It will grow to $15.96 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growing biologics market, increased funding for life sciences research, demand for personalized medicine, expansion of contract manufacturing organizations (CMOS), increasing demand for rapid screen tests. Major trends in the forecast period include single-use systems in protein purification, high-throughput purification technologies, emphasis on continuous processing, integration of automation in protein purification, focus on sustainable and environmentally friendly practices.

The forecast of 11.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff increases could impact U.S. biotech firms by raising expenses for affinity chromatography resins and recombinant protein cleanup systems sourced from Finland and Singapore, potentially reducing therapeutic protein yields and increasing bioprocessing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increase in government spending on research and development in pharmaceuticals and biotechnology is anticipated to drive the growth of the protein purification and isolation market in the future. Research and development involve acquiring knowledge to create new products or find new methods to enhance existing products and services. Increased investment in research and development facilitates the advancement of protein purification processes and offers various benefits, such as purified growth factors, hormones, DNA polymerases, and reverse transcriptase. For example, in March 2023, the White House announced that its budget allocates over $3.4 billion for Cancer Moonshot-related research and development, supporting a range of research programs in laboratory, clinical, public health, and environmental health across multiple departments and agencies. Out of this amount, $2.9 billion is designated for the Department of Health and Human Services, bolstering Cancer Moonshot initiatives at the National Cancer Institute and ARPA-H. Additionally, the budget emphasizes suicide prevention and mental health for veterans, with more than $135 million set aside for the Department of Veterans Affairs medical care. Consequently, the rise in government expenditure on research and development in pharmaceuticals and biotechnology is propelling the growth of the protein purification and isolation markets.

The growing demand for biopharmaceutical products is expected to drive the growth of the protein purification and isolation market in the future. Biopharmaceutical products are large, complex molecules derived from biological sources and are used for therapeutic, diagnostic, or preventive applications. The processes of protein purification and isolation are critical in biopharmaceutical production, as they help obtain highly pure and functional proteins necessary for developing biopharmaceutical drugs such as monoclonal antibodies, vaccines, and therapeutic proteins. For example, in August 2024, the Government of Canada reported that in 2022, domestic exports in the pharmaceutical trade rose to 12.79 billion CAD from 10.71 billion CAD in 2021, while imports increased to 30.21 billion CAD from 26.63 billion CAD in 2021. Therefore, the rising demand for pharmaceutical products is fueling the growth of the protein purification and isolation market.

Major companies in the protein purification and isolation market are developing advanced products, such as Amspher A+, to improve the efficiency and effectiveness of protein separation processes while enhancing yield and purity in biopharmaceutical applications. For example, in September 2024, JSR Life Sciences, LLC, a US-based biotechnology company, launched Amsphere A+. This product features proprietary protein ligand and advanced polymer technology, surpassing its predecessor, Amsphere A3, in terms of binding capacity, alkali stability, and pressure-flow characteristics. These improvements result in greater efficiency in the production process. Overall, Amsphere A+ signifies a notable advancement in performance.

Major players in the protein purification and isolation market are introducing innovative products like affinity resin to enhance their product offerings and maintain a competitive advantage. Affinity resin, a specialized type of chromatography matrix, is designed to selectively bind and purify specific target molecules, particularly proteins or biomolecules, from complex mixtures. Navigo Proteins GmbH introduced an innovative affinity resin in June 2022, utilizing Precision Capturing technology to efficiently capture the glycoprotein gp64 contaminant from the baculovirus insect cell expression system. This resin, designed for flow-through chromatography, allows selective binding, ensuring the target recombinant protein can be eluted without interference, effectively removing contaminants from the production process.

In May 2022, Qiagen N.V., a multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research, acquired BLIRT S.A. for an undisclosed amount. Through this acquisition, Qiagen aims to enhance its capabilities and offerings, ultimately fostering innovation and strengthening its competitive position in these rapidly evolving sectors while providing greater value to its customers and stakeholders. BioLab Innovative Research Technologies (BLIRT S.A.) is a Poland-based biotechnology company engaged in protein purification.

Major companies operating in the protein purification and isolation market include Abcam PLC, Agilent Technologies Inc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., BioVision Inc., Norgen Biotek Corp., GE Healthcare Technologies Inc., GEA Group AG, Expedeon Ltd., Creative Biostructure, Qiagen NV, Geno Technology Inc., The Merck Group, Labome, Promega Corporation, OPRL Biosciences Pvt. Ltd., Purolite LLC, Takara Bio Inc., F. Hoffmann-La Roche Ltd, Sigma-Aldrich Chemicals Private Limited, Cygnus Technologies LLC, Novasep, Kinnakeet Biotechnology LLC, Cambryn Biologics LLC, Worthington Biochemical Corporation, GenScript Biotech Corporation, Creative BioMart, OriGene Technologies Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Sino Biological Inc.

North America was the largest region in the protein purification and isolation market in 2024. The regions covered in the protein purification and isolation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the protein purification and isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The protein purification and isolation market includes revenues earned by entities by isolating one or a few proteins from a complex mixture. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Protein Purification and Isolation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on protein purification and isolation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for protein purification and isolation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The protein purification and isolation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instruments; Consumables
• 2) By Technology: Ultrafiltration; Precipitation; Preparative Chromatography; Electrophoresis; Western Blotting; Dialysis And Diafiltration; Centrifugation
• 3) By Application: Drug Screening; Protein-Protein Interaction Studies; Biomarker Discovery; Target Identification; Protein Therapeutics; Disease Diagnostics And Monitoring
• 4) By End User: Academic Medical Institutes; Hospitals And Diagnostic Centers; Pharmaceutical And Biotechnology Companies; Contract Research Organizations
• Subsegments:
• 1) By Instruments: Chromatography Systems; Centrifuges; Electrophoresis Systems; Filtration Systems; Other Instruments
• 2) By Consumables: Resins And Media; Columns; Kits And Reagents; Membranes; Other Consumables
• Companies Mentioned: Abcam PLC; Agilent Technologies Inc; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; BioVision Inc.; Norgen Biotek Corp.; GE Healthcare Technologies Inc.; GEA Group AG; Expedeon Ltd.; Creative Biostructure; Qiagen NV; Geno Technology Inc.; The Merck Group; Labome; Promega Corporation; OPRL Biosciences Pvt. Ltd.; Purolite LLC; Takara Bio Inc.; F. Hoffmann-La Roche Ltd; Sigma-Aldrich Chemicals Private Limited; Cygnus Technologies LLC; Novasep; Kinnakeet Biotechnology LLC; Cambryn Biologics LLC; Worthington Biochemical Corporation; GenScript Biotech Corporation; Creative BioMart; OriGene Technologies Inc.; Proteintech Group Inc.; Rockland Immunochemicals Inc.; Sino Biological Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.